This inventor holds 2 USPTO granted patents. Top assignee: Aska Pharmaceutical Co., Ltd.. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2023
Title: Tomoya Fujisawa: Innovator in Nasal Administration Technologies
Introduction
Tomoya Fujisawa is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceutical preparations, particularly in the area of nasal administration. With a total of 2 patents to his name, Fujisawa is recognized for his innovative approaches to drug delivery systems.
Latest Patents
Fujisawa's latest patents focus on a powder preparation for nasal administration. This preparation contains a particulate of steroid hormones with an average particle size ranging from 50 to 300 micrometers. The formulation aims to enhance the efficacy of steroid hormones when administered nasally, providing a novel solution for patients requiring such treatments.
Career Highlights
Fujisawa is currently associated with Aska Pharmaceutical Co., Ltd., where he continues to develop and refine his innovative ideas. His work has been instrumental in advancing the field of nasal drug delivery, making significant strides in patient care and treatment options.
Collaborations
Fujisawa collaborates with esteemed colleagues, including Koichi Minato and Kenji Shimizu. Their combined expertise fosters a productive environment for innovation and research within the pharmaceutical industry.
Conclusion
Tomoya Fujisawa's contributions to nasal administration technologies highlight his role as a key inventor in the pharmaceutical field. His innovative patents and collaborations continue to pave the way for advancements in drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile